Search Results - Christophe A. Girard
- Showing 1 - 19 results of 19
-
1
-
2
-
3
-
4
-
5
-
6
Sulfonylurea improves CNS function in a case of intermediate DEND syndrome caused by a mutation in KCNJ11 by Wojciech Młynarski, Andrei I. Tarasov, Agnieszka Gach, Christophe A. Girard, Iwona Pietrzak, Lejla Zubcevic, Jacek Kuśmierek, Tomasz Klupa, Maciej T. Małecki, Frances M. Ashcroft
Published 2007Artigo -
7
A heterozygous activating mutation in the sulphonylurea receptor SUR1 (ABCC8) causes neonatal diabetes by Peter Proks, Amanda L. Arnold, Jan Bruining, Christophe A. Girard, Sarah E. Flanagan, Brian Larkin, Kevin Colclough, Andrew T. Hattersley, Frances M. Ashcroft, Sian Ellard
Published 2006Artigo -
8
-
9
Cancer cell-derived long pentraxin 3 (PTX3) promotes melanoma migration through a toll-like receptor 4 (TLR4)/NF-κB signaling pathway by Moeez Rathore, Christophe A. Girard, Mickaël Ohanna, Mélanie Tichet, Rania Ben Jouira, Esther García, Frédéric Larbret, Maéva Gesson, Stéphane Audebert, J.‐P. Lacour, H. Montaudié, Virginie Prod’homme, Sophie Tartare‐Deckert, Marcel Deckert
Published 2019Artigo -
10
Epitope Spreading of Autoantibody Response to PLA2R Associates with Poor Prognosis in Membranous Nephropathy by Barbara Seitz‐Polski, Guillaume Dolla, Christine Payré, Christophe A. Girard, Joël Polidori, Kévin Zorzi, Eléonore Birgy-Barelli, Perrine Jullien, Cécile Courivaud, Thierry Krummel, Sylvia Benzaken, Ghislaine Bernard, Stéphane Burtey, Christophe Mariat, Vincent Esnault, Gérard Lambeau
Published 2015Artigo -
11
Targeting Discoidin Domain Receptors DDR1 and DDR2 overcomes matrix‐mediated tumor cell adaptation and tolerance to BRAF‐targeted therapy in melanoma by Ilona Berestjuk, Margaux Lecacheur, Alexandrine Carminati, Serena Diazzi, Christopher Rovera, Virginie Prod’homme, Mickaël Ohanna, Ana Popović, Aude Mallavialle, Frédéric Larbret, Sabrina Pisano, Stéphane Audebert, Thierry Passeron, Cédric Gaggioli, Christophe A. Girard, Marcel Deckert, Sophie Tartare‐Deckert
Published 2021Artigo -
12
Permanent Neonatal Diabetes Caused by Dominant, Recessive, or Compound Heterozygous SUR1 Mutations with Opposite Functional Effects by Sian Ellard, Sarah E. Flanagan, Christophe A. Girard, Ann‐Marie Patch, Lorna W. Harries, Andrew Parrish, Emma L. Edghill, Deborah Mackay, Peter Proks, Kenju Shimomura, Holger Haberland, D. J. Carson, Julian Hamilton‐Shield, Andrew T. Hattersley, Frances M. Ashcroft
Published 2007Artigo -
13
Relapsing diabetes can result from moderately activating mutations in KCNJ11 by Anna L. Gloyn, Frank Reimann, Christophe A. Girard, Emma L. Edghill, Peter Proks, Ewan R. Pearson, I. Karen Temple, Deborah Mackay, Julian Hamilton‐Shield, Debra Freedenberg, Kathryn Noyes, Sian Ellard, Frances M. Ashcroft, Fiona M. Gribble, Andrew T. Hattersley
Published 2005Artigo -
14
Group X Secreted Phospholipase A2 Limits the Development of Atherosclerosis in LDL Receptor–Null Mice by Hafid Ait‐Oufella, Olivier Herbin, Charlotte Lahoute, Christelle Coatrieux, Xavier Loyer, Jérémie Joffre, Ludivine Laurans, Bhama Ramkhelawon, Olivier Blanc‐Brude, Sonia Karabina, Christophe A. Girard, Christine Payré, Kei Yamamoto, Christoph J. Binder, Makoto Murakami, Alain Tedgui, Gérard Lambeau, Ziad Mallat
Published 2013Artigo -
15
A Feed-Forward Mechanosignaling Loop Confers Resistance to Therapies Targeting the MAPK Pathway in BRAF-Mutant Melanoma by Christophe A. Girard, Margaux Lecacheur, Rania Ben Jouira, Ilona Berestjuk, Serena Diazzi, Virginie Prod’homme, Aude Mallavialle, Frédéric Larbret, Maéva Gesson, Sébastien Schaub, Sabrina Pisano, Stéphane Audebert, Bernard Mari, Cédric Gaggioli, Eleonora Leucci, Jean‐Christophe Marine, Marcel Deckert, Sophie Tartare‐Deckert
Published 2020Artigo -
16
PLA2R1 Mediates Tumor Suppression by Activating JAK2 by David Vindrieux, Arnaud Augert, Christophe A. Girard, Delphine Gitenay, Hélène Lallet-Daher, Clotilde Wiel, Benjamin Le Calvé, Baptiste Gras, Mylène Ferrand, Stéphanie Verbeke, Yvan de Launoit, Xavier Leroy, Alain Puisieux, Sébastien Aubert, Michaël Perrais, Michael H. Gelb, Hélène Simonnet, Gérard Lambeau, David Bernard
Published 2013Artigo -
17
Expression of an activating mutation in the gene encoding the KATP channel subunit Kir6.2 in mouse pancreatic β cells recapitulates neonatal diabetes by Christophe A. Girard, F. Thomas Wunderlich, Kenju Shimomura, Stephan C. Collins, Stephan Kaizik, Peter Proks, Fernando Abdulkader, Anne Clark, Vicky Ball, Lejla Zubcevic, Liz Bentley, Rebecca Clark, C. Church, Alison Hugill, Juris Galvanovskis, Roger Cox, Patrik Rorsman, Jens C. Brüning, Frances M. Ashcroft
Published 2008Artigo -
18
Control of Pancreatic β Cell Regeneration by Glucose Metabolism by Shay Porat, Noa Weinberg-Corem, Sharona Tornovsky-Babaey, Rachel Ben‐Haroush Schyr, Ayat Hija, Miri Stolovich-Rain, Daniela Dadon, Zvi Granot, Vered Ben-Hur, Peter White, Christophe A. Girard, Rotem Karni, Klaus H. Kaestner, Frances M. Ashcroft, Mark A. Magnuson, Ann Saada, Joseph Grimsby, Benjamin Gläser, Yuval Dor
Published 2011Artigo -
19
The Obesity-Associated<i>FTO</i>Gene Encodes a 2-Oxoglutarate-Dependent Nucleic Acid Demethylase by Thomas Gerken, Christophe A. Girard, Yi‐Chun Loraine Tung, Celia J. Webby, Vladimı́r Saudek, Kirsty S. Hewitson, Giles S.H. Yeo, M.A. McDonough, Sharon L. Cunliffe, Luke A. McNeill, Juris Galvanovskis, Patrik Rorsman, Peter Robins, Xavier Prieur, Anthony P. Coll, Marcella Ma, Z Jovanović, I. Sadaf Farooqi, Barbara Sedgwick, Inês Barroso, Tomas Lindahl, Chris P. Ponting, Frances M. Ashcroft, Stephen O’Rahilly, Christopher J. Schofield
Published 2007Artigo
Search Tools:
Related Subjects
Biology
Gene
Medicine
Biochemistry
Endocrinology
Internal medicine
Genetics
Chemistry
Mutation
Cell biology
Kir6.2
Protein subunit
Cancer research
Diabetes mellitus
Sulfonylurea receptor
Cancer
Glibenclamide
Potassium channel
Biophysics
Cell
Enzyme
Genotype
Immunology
Melanoma
Adenosine triphosphate
FTO gene
Gating
Inflammation
Pancreas
Phenotype